Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3039744	s-rnapol3	— (—)	231	244	100.00%	Distribution not available
3039744	s-rnapoab	— (—)	103	107	100.00%	Distribution not available
3039744	s-rnapol3	u/ml (u/ml)	26	26	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Systemic connective tissue disorders

140

17.86

173.33

1.0

1.1

6.38

3.59

u/ml

—

Other systemic involvement of connective tissue

102

17.12

123.73

1.0

1.1

5.71

3.81

u/ml

—

ILD medications: immunosuppressive drugs

127

122

9.70

105.48

1.0

3.81

1.65

u/ml

—

ILD medications

157

136

6.27

70.66

1.1

1.0

7.20

1.68

u/ml

1.60

ILD medications: prednisolone, methylprednisolone, prednisone

150

134

6.27

68.67

1.1

1.0

7.00

1.68

u/ml

1.67

Reimbursement for rheumatic diseases

109

171

6.37

65.72

1.0

1.1

7.19

3.78

u/ml

—

Second line medication for Crohn's disease

104

176

5.92

58.48

1.0

1.1

4.21

5.28

u/ml

—

Oral corticosteroids

148

173

5.08

57.44

1.0

1.1

5.88

1.45

u/ml

—

L04AX Other immunosuppressants

101

173

5.85

56.10

1.0

1.1

4.21

5.28

u/ml

—

Inflammatory bowel disease treatment related agents

152

179

4.76

53.62

1.1

6.71

1.45

u/ml

—

ILD, hospital admissions

14.92

48.49

1.0

1.1

5.50

1.80

u/ml

—

Other interstitial pulmonary diseases

14.92

48.49

1.0

1.1

5.50

1.80

u/ml

—

Interstitial lung disease endpoints

14.92

48.49

1.0

1.1

5.50

1.80

u/ml

—

Interstitial lung disease

14.92

48.49

1.0

1.1

5.50

1.80

u/ml

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

27.79

44.28

1.0

5.50

—

u/ml

—

Other respiratory diseases principally affecting the interstitium

11.06

41.50

1.0

1.1

5.50

2.57

u/ml

—

Pain in joint

5.90

39.07

1.0

1.1

3.00

5.17

u/ml

—

First line medication for Crohn's disease

124

155

4.33

38.97

1.0

1.1

7.20

1.45

u/ml

—

Autoimmune diseases excluding thyroid diseases

123

161

4.17

37.23

1.1

1.0

2.55

u/ml

0.00

Autoimmune diseases excluding thyroid diseases, strict definition

118

157

4.12

35.26

1.1

1.0

2.50

2.55

u/ml

0.02

Autoimmune diseases related-to ILD

102

224

3.90

33.46

1.0

1.1

5.93

3.64

u/ml

—

Diseases of arteries, arterioles and capillaries

136

4.57

32.00

1.1

1.0

6.40

5.41

u/ml

—

Abnormal findings on diagnostic imaging of lung

124

4.65

25.61

1.1

1.0

9.63

2.62

u/ml

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

179

3.80

24.54

1.1

1.0

9.78

2.38

u/ml

—

Autoimmune diseases

104

161

3.29

22.55

1.1

1.0

6.30

2.55

u/ml

—

Renal failure

103

4.30

18.99

1.1

1.0

6.17

5.96

u/ml

—

Used for control exclusion in common control thyroid runs

149

3.12

18.51

1.1

1.0

5.67

2.56

u/ml

—

Rheumatoid arthritis, including avohilmo

123

4.07

18.39

1.0

6.71

3.36

u/ml

—

Abnormalities of breathing

172

2.97

17.26

1.0

1.1

7.41

3.15

u/ml

0.71

Implicit bacterial Sepsis

106

3.83

15.32

1.1

1.0

9.06

3.25

u/ml

—

All chronic kidney diseases

134

3.42

15.27

1.1

1.0

2.00

4.35

u/ml

—

Gastro-oesophageal reflux disease

205

2.91

14.66

1.0

3.00

4.91

u/ml

—

Bacterial Sepsis

113

3.63

14.50

1.1

1.0

8.45

3.14

u/ml

—

Implicit bacterial Sepsis

3.89

14.45

1.1

1.0

9.06

3.25

u/ml

—

Dyspnoea

243

2.59

13.99

1.0

1.1

9.75

2.60

u/ml

—

Bacterial infection, other or unspecified

148

3.20

13.94

1.1

1.0

8.20

3.61

u/ml

—

Systemic lupus erythematosus

34.39

13.51

1.1

1.2

—

SLE, ICD10

22.79

12.91

1.1

—

SLE, strict definition

22.79

12.91

1.1

—

Fever of other and unknown origin

152

3.11

12.77

1.0

2.30

2.63

u/ml

—

Other bacterial diseases

217

2.54

12.76

1.1

1.0

7.04

2.81

u/ml

0.79

Diseases of oesophagus, stomach and duodenum

237

2.40

12.71

1.1

1.0

5.11

4.21

u/ml

0.13

Other bacterial diseases

238

2.43

12.69

1.1

1.0

7.50

2.76

u/ml

0.83

Bacterial infection, other or unspecified

136

3.19

12.52

1.1

1.0

8.20

3.61

u/ml

—

Renal tubulo-interstitial diseases

238

2.44

11.53

1.1

1.0

8.69

3.00

u/ml

—

Hypothyroidism, strict autoimmune

135

2.88

11.52

1.0

12.25

2.60

u/ml

—

Systemic lupus erythematosus, unspecified

25.30

11.15

1.1

1.2

—

Dermatitis and eczema

262

2.22

10.83

1.1

1.0

3.21

4.87

u/ml

—

Symptoms and signs involving the digestive system and abdomen

166

2.45

10.78

1.1

1.0

5.65

4.82

u/ml

—

Persons encountering health services in other circumstances, wide

219

2.23

10.51

1.1

1.0

6.82

3.19

u/ml

0.58

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

260

2.26

10.40

1.1

1.0

7.77

2.65

u/ml

0.94

Heart failure, not strict

157

2.64

10.34

1.0

9.44

2.61

u/ml

—

Abdominal and pelvic pain

166

2.36

9.71

1.1

1.0

3.08

4.82

u/ml

—

Implicit Sepsis

208

2.39

9.64

1.1

1.0

8.94

2.53

u/ml

—

General symptoms and signs

186

2.26

9.54

1.1

1.0

8.70

2.64

u/ml

—

Diseases of the skin and subcutaneous tissue

174

2.31

9.48

1.1

1.0

3.81

5.31

u/ml

—

Implicit Sepsis

195

2.44

9.40

1.1

1.0

9.06

2.59

u/ml

—

Condition for Implicit Sepsis (Organ dysfunction codes)

216

2.29

8.97

1.1

1.0

7.77

2.53

u/ml

0.96

Persons encountering health services for other counselling and medical advice, not elsewhere classified

219

2.13

8.76

1.0

6.64

3.19

u/ml

0.54

Headache

178

2.47

8.58

1.1

1.0

6.57

2.70

u/ml

—

Localized scleroderma [morphea]

+∞

8.35

1.1

0.0

—

Bacterial intestinal infections, IBD co-morbidities

4.08

8.24

1.0

1.1

7.00

3.81

u/ml

—

Other diseases of pleura

111

2.92

8.15

1.0

1.1

11.90

3.78

u/ml

—

Other bacterial intestinal infections

4.01

8.05

1.0

7.00

3.81

u/ml

—

All kidney diseases

264

2.07

8.05

1.1

1.0

7.83

3.11

u/ml

—

Pain (limb, back, neck, head abdominally)

2.67

7.96

1.1

4.25

4.95

u/ml

—

Abnormalities of heart beat

102

3.08

7.90

1.1

1.0

2.60

3.56

u/ml

—

Pneumonia, organism unspecified

237

2.13

7.83

1.1

1.0

8.20

2.69

u/ml

—

Condition for Implicit Sepsis (Organ dysfunction codes)

229

2.14

7.77

1.1

1.0

7.37

2.64

u/ml

0.93

Other bacterial intestinal infections

3.53

7.40

1.0

7.00

3.81

u/ml

—

Influenza and pneumonia

263

1.98

7.26

1.1

1.0

8.89

2.69

u/ml

—

Symptoms and signs involving the skin and subcutaneous tissue

274

2.14

7.13

1.1

1.0

1.92

5.32

u/ml

—

Asthma, excluding more controls

112

2.42

7.02

1.1

5.00

1.93

u/ml

—

Complications of surgical and medical care, not elsewhere classified

271

1.97

6.94

1.1

6.00

4.20

u/ml

—

Asthma

117

2.38

6.90

1.1

5.00

1.93

u/ml

—

Complications of procedures, not elsewhere classified

265

2.06

6.90

1.1

1.0

6.00

4.30

u/ml

—

Symptoms and signs involving the circulatory and respiratory systems

173

2.09

6.87

1.0

1.1

6.25

3.15

u/ml

—

Cough

114

2.74

6.64

1.0

6.67

3.67

u/ml

—

204

2.05

6.63

1.1

1.0

8.78

2.25

u/ml

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

204

2.05

6.63

1.1

1.0

8.78

2.25

u/ml

—

Malaise and fatigue

120

2.55

6.43

1.1

1.0

6.90

2.71

u/ml

—

Other pulmonary diagnosis

119

2.27

6.34

1.0

1.1

7.21

2.94

u/ml

—

Haemolytic-uraemic syndrome

+∞

6.32

1.0

0.0

—

Episodal and paroxysmal disorders

217

1.90

6.09

1.0

1.1

7.62

2.50

u/ml

1.04

Gout, unspecified

3.76

6.08

1.1

5.44

3.60

u/ml

—

Gout, FINNGEN

3.33

5.95

1.1

1.0

5.44

3.60

u/ml

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

267

1.89

5.90

1.1

1.0

8.20

2.69

u/ml

—

GASTRO-related operations

124

2.18

5.83

1.1

3.08

3.69

u/ml

—

Any gastric operation

124

2.18

5.83

1.1

3.08

3.69

u/ml

—

Diseases of the ear and mastoid process

243

1.82

5.80

1.0

1.1

3.35

5.33

u/ml

—

Pneumonias (Asthma/COPD co-morbidities)

269

1.87

5.79

1.1

1.0

8.20

2.69

u/ml

—

All pneumoniae

269

1.86

5.72

1.1

1.0

8.20

2.69

u/ml

—

Gout, idiopatic and unspecified

3.34

5.71

1.1

5.44

2.86

u/ml

—

Persons encountering health services for specific procedures and health care

266

1.83

5.67

1.0

1.1

6.69

3.71

u/ml

—

Nerve, nerve root and plexus disorders

264

1.83

5.62

1.1

1.0

6.06

4.00

u/ml

—

Disorders of the thyroid gland

245

1.89

5.60

1.1

9.81

2.53

u/ml

—

Other and unspecified anaemias

122

2.50

5.45

1.1

1.0

7.70

5.50

u/ml

—

Tramadol

182

1.99

5.37

1.0

5.06

5.18

u/ml

—

Other anaemias

123

2.47

5.34

1.1

1.0

7.70

5.50

u/ml

—

Soft tissue disorders

200

1.85

5.13

1.0

1.1

5.28

4.87

u/ml

—

Other heart diseases, wide

228

1.85

5.10

1.1

1.0

6.63

2.38

u/ml

—

Aplastic and other anaemias

129

2.39

5.09

1.1

1.0

7.70

5.20

u/ml

—

Psoriatic and enteropathic arthropathies

6.33

5.07

1.1

—

Seropositive rheumatoid arthritis, wide

2.76

5.02

1.1

1.0

8.80

3.94

u/ml

—

Excluding asthma or asthma-COPD overlap

119

2.11

5.00

1.0

1.1

2.90

2.94

u/ml

—

Sleep disorders (combined)

242

1.76

4.91

1.0

7.89

3.24

u/ml

—

COPD differential diagnosis

120

2.09

4.90

1.0

1.1

4.08

1.93

u/ml

—

ILD differential diagnosis

120

2.09

4.90

1.0

1.1

4.08

1.93

u/ml

—

Sleep apnoea

238

1.82

4.81

1.0

1.1

9.71

3.13

u/ml

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

251

1.80

4.80

1.0

1.1

10.79

2.53

u/ml

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

264

1.78

4.76

1.1

1.0

6.17

4.66

u/ml

—

Complications of medical and surgical care

267

1.89

4.75

1.1

1.0

6.60

4.25

u/ml

—

Hypothyroidism, other/unspecified

239

1.82

4.71

1.0

1.1

12.25

2.50

u/ml

—

Other disorders of lacrimal gland

121

2.40

4.62

1.1

1.0

—

4.93

—

COPD/asthma related infections

204

1.77

4.44

1.0

7.22

2.25

u/ml

—

COPD/asthma/ILD related infections

204

1.77

4.44

1.0

7.22

2.25

u/ml

—

Neurological diseases

151

1.90

4.37

1.1

1.0

2.44

3.07

u/ml

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

228

1.95

4.31

1.1

1.0

6.60

4.40

u/ml

—

Kidney transplant status

8.92

4.28

1.1

1.0

—

Septicaemia

106

2.38

4.21

1.0

13.00

3.61

u/ml

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

2.59

4.13

1.1

1.0

8.80

4.19

u/ml

—

Other disorders of ear

241

1.74

4.01

1.1

1.0

2.86

5.61

u/ml

—

Disorders of lacrimal system

155

2.13

4.01

1.1

1.0

—

4.58

—

Heart failure,strict

102

2.21

4.01

1.1

1.0

10.50

2.89

u/ml

—

Gastrointestinal diseases

2.09

3.99

1.1

1.0

3.40

1.50

u/ml

—

Other and unspecified iron deficiency

111

2.34

3.97

1.1

1.0

12.75

2.95

u/ml

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

273

1.70

3.96

1.1

2.09

6.08

u/ml

1.26

Other/unspecified seropositive rheumatoid arthritis

2.53

3.95

1.1

1.0

8.80

3.94

u/ml

—

Explicit Sepsis

122

2.22

3.88

1.0

13.00

3.25

u/ml

—

241

1.65

3.83

1.1

1.0

10.38

2.36

u/ml

—

Glomerular diseases

3.07

3.80

1.1

1.0

—

3.79

—

Diseases of the respiratory system

2.07

3.73

1.1

4.08

2.00

u/ml

—

Disorders of vitreous body

161

2.04

3.73

1.1

1.0

1.83

6.69

u/ml

—

Nutritional anaemias

161

2.04

3.71

1.1

1.0

9.17

2.73

u/ml

—

Acute upper respiratory infections

259

1.64

3.52

1.0

1.1

13.00

2.31

u/ml

—

Disorders of vitreous body and globe

164

1.99

3.51

1.1

1.0

1.83

6.69

u/ml

—

Erysipelas

182

1.85

3.50

1.0

8.70

3.00

u/ml

—

Exposure to other specified factors

275

1.74

3.50

1.0

1.1

6.20

4.28

u/ml

—

Iron deficiency anaemia

143

2.07

3.44

1.1

1.0

11.21

2.79

u/ml

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

246

1.67

3.43

1.0

1.1

12.25

2.58

u/ml

—

Acute tubulo-interstitial nephritis

184

1.88

3.42

1.1

1.0

7.90

3.30

u/ml

—

Diarrhoea and gastroenteritis of presumed infectious origin

276

1.62

3.39

1.1

2.60

4.21

u/ml

—

Other and unspecified rosacea

4.08

3.39

1.1

—

3.40

—

Other disorders of eye and adnexa

3.10

3.36

1.1

—

3.79

—

Hard cardiovascular diseases

190

1.73

3.36

1.1

1.0

5.75

4.70

u/ml

—

Heart failure, strict

121

1.98

3.29

1.1

1.0

9.56

3.70

u/ml

—

Hypertensive diseases

185

1.71

3.27

1.0

7.21

5.14

u/ml

—

Chronic tubulo-interstitial nephritis

8.60

3.26

1.2

1.0

—

Reactive arthropathies, FINNGEN

6.37

3.18

1.1

1.2

—

All-cause Heart Failure

118

1.97

3.17

1.1

9.56

3.70

u/ml

—

Sleep apnoea, including avohilmo

254

1.61

3.16

1.0

1.1

9.71

3.02

u/ml

—

Cardiac arrhythmias

165

1.77

3.09

1.1

1.0

6.36

3.79

u/ml

—

Other arrhythmias

177

1.79

3.07

1.1

1.0

3.94

2.45

u/ml

—

Hypertension

185

1.68

3.04

1.0

7.21

5.14

u/ml

—

Alopecia areata

10.04

2.98

1.0

1.2

—

Disorders of skin appendages

183

1.86

2.93

1.0

1.1

—

5.75

—

Chronic lower respiratory diseases

272

1.53

2.93

1.1

6.67

3.55

u/ml

—

Dizziness and giddiness

231

1.68

2.93

1.1

1.75

6.21

u/ml

—

Intestinal infectious diseases

275

1.54

2.91

1.0

1.1

5.50

4.21

u/ml

—

Other chronic obstructive pulmonary disease, including avohilmo

133

1.93

2.89

1.0

3.90

6.34

u/ml

—

Psoriatic arthropathies

4.10

2.88

1.1

1.0

—

Certain infectious and parasitic diseases

189

1.62

2.87

1.0

10.06

2.54

u/ml

—

Biological medication for rheuma

2.59

2.87

1.0

—

3.40

—

Varicella [chickenpox]

6.67

2.86

1.0

1.1

—

Presence of cardiac and vascular implants and grafts

2.09

2.83

1.0

6.50

7.07

u/ml

—

Non-ischemic cardiomyopathy

2.23

2.81

1.1

7.25

2.33

u/ml

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

135

1.98

2.81

1.0

1.1

6.90

5.54

u/ml

—

Pericarditis

8.36

2.75

1.2

1.0

—

Polyarthritis, unspecified

8.36

2.75

1.0

—

Congenital deformities of feet

8.35

2.75

1.2

—

Other and unspecified disorders of vitreous body

143

1.93

2.73

1.0

1.60

7.46

u/ml

—

Crohn disease (strict definition, require KELA, min 2 HDR)

5.01

2.73

1.0

1.1

—

Rosacea

3.00

2.69

1.1

—

3.00

—

Intestinal infectious diseases

292

1.56

2.68

1.1

1.0

6.33

4.11

u/ml

—

Opioids

201

1.58

2.65

1.0

2.75

5.18

u/ml

—

Diseases of the eye and adnexa

155

1.65

2.62

1.0

1.1

3.40

4.80

u/ml

—

Symptoms and signs involving the urinary system

212

1.65

2.60

1.1

1.0

3.81

5.56

u/ml

—

Covid-19 suspected case

2.30

2.57

1.1

—

3.50

—

Endometriosis of rectovaginal septum and vagina

4.01

2.56

1.0

1.1

—

Erysipelas

150

1.83

2.54

1.1

1.0

8.70

3.61

u/ml

—

Spondylopathies

170

1.65

2.54

1.0

1.1

5.43

3.79

u/ml

—

Hypertension, essential

183

1.61

2.51

1.0

7.92

5.14

u/ml

—

Deep endometriosis

3.23

2.51

1.0

1.1

—

4.75

—

Syncope and collapse

109

1.96

2.51

1.1

1.0

4.33

2.86

u/ml

—

Benzodiazepine use

291

1.51

2.49

1.0

1.1

7.60

3.86

u/ml

—

Spinal stenosis

107

1.92

2.48

1.0

5.43

4.23

u/ml

—

Leiomyoma of uterus

162

1.64

2.48

1.0

1.1

6.17

3.88

u/ml

—

Migraine without aura

2.32

2.47

1.2

1.1

—

3.10

—

Cervicalgia

2.38

2.45

1.0

—

4.79

—

Bronchitis

283

1.49

2.40

1.1

1.0

8.43

3.25

u/ml

—

L04AC Interleukin inhibitors

5.01

2.40

1.0

1.1

—

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

6.27

2.37

1.0

1.1

—

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

6.27

2.37

1.0

1.1

—

Varicella [chickenpox]

6.26

2.37

1.0

1.1

—

Open wound of lower leg

2.61

2.35

1.2

1.0

—

2.79

—

Lower back pain or/and sciatica

291

1.48

2.32

1.0

1.1

1.33

5.27

u/ml

—

Presence of other devices

2.25

2.31

1.0

1.1

2.60

7.44

u/ml

—

Ulcer of lower limb, not elsewhere classified

3.22

2.30

1.1

—

3.58

—

Codeine or tramadol medication

266

1.46

2.26

1.1

1.0

2.58

5.66

u/ml

—

Conductive and sensorineural hearing loss

191

1.59

2.19

1.0

3.20

5.61

u/ml

—

Cerebrovascular diseases

173

1.62

2.14

1.1

1.0

2.89

6.28

u/ml

—

Stroke, including SAH

146

1.69

2.12

1.1

1.0

1.57

7.17

u/ml

—

Coagulation defects, purpura and other haemorrhagic conditions

2.37

2.12

1.0

1.1

—

3.81

—

Infections with a predominantly sexual mode of transmission

123

1.87

2.09

1.1

—

4.10

—

Bacterial pneumonia (organism specified)

131

1.80

2.09

1.0

7.00

5.35

u/ml

—

Other predominantly sexually transmitted diseases, not elsewhere classified

2.26

2.07

1.1

1.0

—

3.50

—

Other psoriatic arthropathies

2.91

2.07

1.1

—

3.40

—

Other Crohn's disease

4.01

2.04

1.0

1.1

—

STROKE

128

1.70

2.03

1.1

1.0

1.57

5.38

u/ml

—

Seropositive rheumatoid arthritis, strict definition

2.40

2.02

1.0

1.1

8.80

3.25

u/ml

—

Keratitis

125

1.84

2.01

1.0

—

7.07

—

Benign neoplasm: Caecum

3.08

2.01

1.1

1.0

—

3.10

—

Abnormal findings on diagnostic imaging of other body structures

2.63

2.00

1.1

1.0

—

3.00

—

Acute upper respiratory infections of multiple and unspecified sites

222

1.54

2.00

1.1

1.0

10.80

2.36

u/ml

—

Other disorders of urethra and urinary system

222

1.53

1.99

1.0

1.1

6.67

4.18

u/ml

—

Tumor necrosis factor alpha inhibitors

2.36

1.94

1.0

—

3.40

—

Tobacco use

4.55

1.94

1.2

1.1

—

Other dorsopathies, not elsewhere classified

211

1.46

1.93

1.0

1.1

11.08

3.60

u/ml

—

Psoriatic arthropathies, ICD10

2.73

1.93

1.1

—

3.40

—

Purpura and other haemorrhagic conditions

2.73

1.93

1.0

1.1

—

4.90

—

Vocal cord dysfunction

3.31

1.92

1.0

—

Unspecified mental disorder

155

0.39

1.88

1.0

1.1

—

5.21

—

Endocrine, nutritional and metabolic diseases

172

1.50

1.88

1.1

1.0

3.79

3.00

u/ml

—

Bacterial pneumoniae

106

1.83

1.87

1.0

7.00

3.60

u/ml

—

Diseases of pulp and periapical tissues, including avohilmo

237

1.42

1.83

1.1

1.0

1.70

5.70

u/ml

—

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

3.53

1.83

1.0

1.1

—

Paracetamol or NSAID medication

2.83

1.82

1.1

1.0

—

Sequelae of other external causes

4.17

1.82

1.2

1.1

—

Alcohol-induced chronic pancreatitis

4.17

1.82

1.0

—

Acute lymphadenitis

4.17

1.82

1.2

1.0

—

Other noninfective gastroenteritis and colitis

2.05

1.79

1.1

1.0

—

3.72

—

Kela-code for severe mental illness

136

0.37

1.74

1.0

—

5.92

—

Other symptoms and signs involving cognitive functions and awareness

133

1.71

1.74

1.0

2.50

9.45

u/ml

—

Arthropathic psoriasis

2.50

1.74

1.2

1.1

—

3.40

—

Inflammatory disease of uterus

2.22

1.73

1.1

—

4.60

—

Fitting and adjustment of other devices

1.86

1.73

1.0

1.1

3.17

5.85

u/ml

—

Retinal breaks without detachment

2.29

1.70

1.0

—

4.30

—

Haemorrhoids and perianal venous thrombosis

103

1.84

1.70

1.0

1.1

2.20

3.44

u/ml

—

Other sexually transmitted chlamydial diseases

3.16

1.66

1.2

1.1

—

Behavioural syndromes associated with physiological disturbances and physical factors

282

1.41

1.63

1.1

1.0

6.60

4.20

u/ml

—

Congenital malformations of eye, ear, face and neck

3.58

1.61

1.0

1.1

—

Bacterial pneumonia, not elsewhere classified

1.78

1.59

1.1

1.0

7.00

3.83

u/ml

—

Use of hypnotics and sedatives

262

1.38

1.59

1.0

1.1

2.88

5.38

u/ml

—

Sleep disorders

278

1.40

1.56

1.1

1.0

6.60

4.20

u/ml

—

Metabolic disorders

244

1.40

1.55

1.1

1.0

6.58

4.33

u/ml

—

Dorsopathies

211

1.40

1.54

1.0

1.1

5.93

3.60

u/ml

—

Asthma, including avohilmo

287

1.35

1.53

1.1

1.0

5.00

4.38

u/ml

—

Shoulder lesions

168

1.48

1.51

1.0

1.1

1.60

5.13

u/ml

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

123

1.71

1.50

1.1

1.0

—

5.57

—

Superficial injury of lower leg

1.90

1.49

1.0

—

6.05

—

Retinal detachments and breaks

116

1.72

1.48

1.1

1.0

—

7.10

—

Fracture of femur

1.95

1.48

1.1

1.90

5.55

u/ml

—

Sensorineural hearing loss

179

1.48

1.1

1.0

3.20

5.86

u/ml

—

Crohn disease

2.43

1.47

1.0

1.1

—

3.40

—

Stroke, excluding SAH

140

1.56

1.47

1.1

1.0

1.57

7.17

u/ml

—

Other complications of surgical and medical care, not elsewhere classified

2.50

1.45

1.0

1.1

—

4.50

—

Recurrent dislocation and subluxation of joint

3.13

1.44

1.0

1.1

—

Migraine without aura and triptan purchases

2.04

1.43

1.2

1.1

—

1.50

—

Other inflammation of eyelid

2.31

1.43

1.1

—

3.92

—

Constipation

243

1.40

1.39

1.0

7.10

4.58

u/ml

—

Exclusions for E4_PCOS_CONSORTIUM

209

1.41

1.38

1.0

1.1

7.50

3.39

u/ml

—

Pollen allergy

1.95

1.38

1.1

—

3.25

—

Other diseases of intestines

263

1.34

1.35

1.0

1.1

9.06

2.44

u/ml

—

Myocardial infarction, without ST-elevation

103

1.68

1.29

1.1

—

5.75

—

Primary hyperparathyroidism

2.29

1.26

1.0

1.1

—

2.93

—

Injuries to the hip and thigh

146

1.55

1.26

1.1

1.90

7.46

u/ml

—

Nonsuppurative otitis media

1.84

1.25

1.0

1.1

—

3.56

—

Other predominantly sexually transmitted diseases, not elsewhere classified

1.82

1.25

1.1

—

2.93

—

Schizophrenia or delusion

118

0.42

1.24

1.0

—

6.18

—

Schizophrenia, schizotypal and delusional disorders

119

0.42

1.23

1.0

—

6.18

—

Ulcerative colitis, NAS

2.00

1.23

1.0

—

3.40

—

Viral hepatitis

2.63

1.21

1.2

1.0

—

Infections with a predominantly sexual mode of transmission

152

1.53

1.21

1.1

—

3.82

—

Degenerative macular diseases

2.31

1.18

1.0

1.1

—

3.50

—

Bleeding

216

1.38

1.18

1.1

1.0

8.06

3.17

u/ml

—

Chronic sinusitis

157

1.53

1.16

1.0

1.1

—

6.63

—

Use of rivastigmine

0.00

1.16

0.0

1.1

—

2.94

—

Other embolism and thrombosis

2.05

1.15

1.0

1.1

—

4.06

—

Noninfectious colitis NAS

2.05

1.15

1.0

1.1

—

3.69

—

Benign neoplasm of meninges

0.00

1.14

0.0

1.1

—

2.75

—

Benign neoplasm: Ascending colon

2.00

1.12

1.0

1.1

—

2.93

—

Pregnancy, childbirth and the puerperium

0.46

1.10

1.0

—

2.06

—

Diabetic nephropathy

1.97

1.10

1.3

1.1

—

5.11

—

Benign neoplasm of other and unspecified endocrine glands

1.95

1.08

1.0

1.1

—

3.79

—

Fall on same level

278

1.28

1.05

1.0

1.1

6.36

4.25

u/ml

—

Schizophrenia or delusion, excluding more controls

106

0.47

1.00

1.0

—

5.83

—

Chronic periodontitis, including avohilmo

269

1.30

0.99

1.1

1.93

5.41

u/ml

—

Car occupant injured in other and unspecified transport accidents

1.80

0.98

1.1

—

4.25

—

Periodontitis

269

1.29

0.97

1.1

1.93

5.41

u/ml

—

Pedal cyclist injured in noncollision transport accidents

0.00

0.97

0.0

1.1

—

3.40

—

Ischaemic Stroke, excluding all haemorrhages

134

1.44

0.96

1.1

1.0

1.30

6.91

u/ml

—

Hypo-osmolality and hyponatraemia

1.79

0.96

1.1

1.0

—

6.00

—

Benign neoplasm: Cerebral meninges

0.00

0.95

0.0

1.1

—

2.75

—

Chondropathies

1.73

0.92

1.1

—

3.79

—

Zoster [herpes zoster]

1.73

0.92

1.0

1.1

—

2.94

—

Thyrotoxicosis

1.63

0.90

1.1

1.0

—

6.45

—

Thyrotoxicosis, other and/or unspecified

1.75

0.90

1.2

1.0

—

3.06

—

Diabetic nephropathy, excluding more controls

1.94

0.89

1.3

1.1

—

6.33

—

Retinal vascular occlusion

2.07

0.89

1.0

1.1

—

3.50

—

Hydronephrosis

2.07

0.89

1.0

1.1

—

4.21

—

Malignant neoplasm of digestive organs

103

0.54

0.89

1.0

—

3.50

—

Long labour

101

1.53

0.89

1.1

1.0

—

3.10

—

Complications predominantly related to the puerperium

111

1.53

0.87

1.2

1.0

—

3.82

—

Retinal vascular disorders

2.00

0.87

1.0

1.1

—

3.50

—

Chronic rhinitis, nasopharyngitis and pharyngitis

112

1.52

0.84

1.0

1.1

—

7.83

—

Other medical care

130

1.45

0.84

1.0

—

5.13

—

D07AA Corticosteroids, weak (group I)

1.78

0.84

1.0

—

3.40

—

Psoriasis vulgaris

1.76

0.83

1.1

—

3.79

—

Other intervertebral disc disorders

195

1.30

0.82

1.0

1.1

8.50

3.60

u/ml

—

Necrosis of pulp, including avohilmo

239

1.34

0.82

1.0

1.1

2.00

6.14

u/ml

—

Medical treatment for female infertility

1.54

0.79

1.0

1.1

—

2.90

—

Pregnancy with abortive outcome

156

1.30

0.78

1.1

8.40

3.33

u/ml

—

Selective serotonin reuptake inhibitors

226

1.25

0.78

1.1

1.0

6.22

4.00

u/ml

—

L02BG Aromatase inhibitors

121

0.58

0.77

1.0

—

5.30

—

Viral and other specified intestinal infections

1.52

0.76

1.1

—

3.35

—

Corneal ulcer

1.70

0.75

1.1

—

4.25

—

Acute laryngitis and tracheitis

1.81

0.73

1.0

—

Myocardial infarction, with ST-elevation

1.80

0.72

1.0

1.1

—

2.67

—

DVT of lower extremities

1.61

0.72

1.0

—

3.72

—

Fracture of rib(s), sternum and thoracic spine

1.52

0.72

1.0

1.1

—

3.63

—

Other disorders of bone

1.67

0.72

1.1

—

3.79

—

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

1.92

0.70

1.0

1.1

—

1.60

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

265

1.23

0.70

1.0

1.1

8.08

3.95

u/ml

—

Nontoxic multinodular goitre

1.55

0.69

1.0

1.1

—

2.80

—

Other metabolic disorders

1.67

0.68

1.0

1.1

—

4.00

—

Mycoses

316

1.24

0.68

1.1

7.20

3.94

u/ml

—

Artrosis, including avohilmo

183

1.26

0.67

1.0

1.1

1.40

5.37

u/ml

—

Rash and other nonspecific skin eruption

1.79

0.66

1.4

1.1

—

4.90

—

Other mental disorders due to brain damage and dysfunction and to physical disease

1.79

0.66

1.2

1.0

—

3.90

—

Biguanides

262

0.79

0.64

1.1

1.0

2.67

5.45

u/ml

—

Ptosis of eyelid

1.72

0.64

1.0

1.1

—

2.70

—

Disorders of gallbladder, biliary tract and pancreas

272

1.21

0.60

1.0

1.1

8.20

3.89

u/ml

—

Myocardial infarction

109

1.35

0.60

1.1

1.0

—

5.12

—

Antepartum haemorrhage, not elsewhere classified

1.67

0.56

1.0

1.1

—

2.90

—

Bitten or struck by other mammals

1.67

0.56

1.0

1.1

—

3.40

—

Other congenital malformations

1.62

0.55

1.0

1.1

—

3.40

—

Gingivitis and periodontal diseases

225

1.19

0.54

1.1

1.0

2.21

5.89

u/ml

—

FESS (DNB20)

1.58

0.54

1.0

1.1

—

3.40

—

Unspecified lump in breast

1.45

0.53

1.0

—

7.15

—

Hernia

264

1.19

0.52

1.1

1.0

3.42

5.30

u/ml

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

1.50

0.51

1.0

1.1

—

4.00

—

Ethmoidectomy

1.50

0.51

1.0

1.1

—

3.40

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

1.51

0.48

1.0

—

3.40

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

1.45

0.46

1.0

1.1

—

4.25

—

Combinations of oral blood glucose lowering drugs

0.60

0.45

1.0

—

7.94

—

Endometriosis ASRM stages 1,2

1.43

0.45

1.1

—

4.75

—

Exclusions for E4_PCOS_BROAD

1.37

0.44

1.1

—

4.25

—

Erosion of teeth , including avohilmo

1.38

0.42

1.1

—

3.50

—

Use of pramipexole

1.43

0.41

1.0

—

6.15

—

Sequelae of injuries, of poisoning and of other consequences of external causes

1.43

0.41

1.0

—

6.44

—

Benign neoplasms

223

1.16

0.40

1.0

1.1

2.50

4.03

u/ml

—

Disorders of continuity of bone

1.47

0.40

1.0

1.1

—

4.90

—

Benign neoplasm of mouth and pharynx

1.47

0.40

1.2

1.1

—

2.75

—

Alzheimer’s disease (Atypical or mixed)

0.00

0.40

0.0

1.0

—

2.40

—

Premature rupture of membranes

1.34

0.39

1.3

1.0

—

2.90

—

Falls/tendency to fall

245

1.14

0.39

1.1

2.86

4.53

u/ml

—

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

1.43

0.39

1.0

1.1

—

4.70

—

Malignant neoplasm

224

1.16

0.39

1.0

7.00

3.15

u/ml

—

Viral and other specified intestinal infections

1.33

0.37

1.0

1.1

—

3.56

—

Nontoxic goitre/thyroid nodule

107

1.31

0.37

1.1

1.0

—

5.54

—

Bipolar affective disorders

1.27

0.36

1.0

—

2.92

—

Voice disturbances

1.33

0.35

1.0

—

7.00

—

Malignant neoplasm of breast, HER-negative

0.62

0.35

1.0

—

4.39

—

Skin changes due to chronic exposure to nonionizing radiation

108

1.28

0.34

1.1

1.0

—

4.88

—

Thyrotoxicosis with diffuse goitre

1.36

0.34

1.2

1.0

—

2.93

—

Pain in thoracic spine

1.36

0.34

1.0

—

5.25

—

Recurrent aphthous stomatitis , including avohilmo

1.33

0.33

1.2

1.1

—

3.81

—

Injuries to the head

306

1.12

0.33

1.1

2.57

5.07

u/ml

—

Solid cancers, helper endpoint

223

1.14

0.31

1.0

7.00

3.15

u/ml

—

Actinic keratosis

102

1.27

0.31

1.1

1.0

—

4.88

—

Other diseases of urinary system

250

1.12

0.30

1.0

1.1

6.31

4.06

u/ml

—

Striking against or struck by other objects

111

1.26

0.29

1.1

—

5.09

—

Puerperal sepsis

1.25

0.29

1.0

1.1

—

5.21

—

Unstable angina pectoris

0.73

0.29

1.0

—

4.86

—

Conjunctivitis (acute, non atopic)

1.29

0.29

1.0

—

3.65

—

Postpartum hemorraghe, parous women as controls

1.25

0.28

1.1

—

4.50

—

Carbimazole or st.post thyroidectomy, condition for graves disease

1.32

0.28

1.2

1.0

—

4.18

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

102

1.26

0.27

1.1

—

2.50

—

Substance use, excluding alcohol

1.23

0.27

1.0

—

7.00

—

Peritonsillar abscess

1.23

0.27

1.1

—

5.93

—

Other strabismus

0.68

0.26

1.0

1.1

—

3.79

—

Maternal care for known or suspected fetal abnormality and damage

1.23

0.25

1.2

1.0

—

2.90

—

Postpartum hemorraghe, all women as controls

113

1.22

0.23

1.1

—

2.75

—

Varicose veins

184

0.86

0.23

1.0

9.50

4.12

u/ml

—

False labour

0.81

0.23

1.0

—

2.90

—

Type 2 diabetes, strict (exclude DM1)

256

1.10

0.22

1.0

5.57

4.39

u/ml

—

Type 2 diabetes, definitions combined

256

1.10

0.22

1.0

5.57

4.39

u/ml

—

Triptan medication for migraine, single purchase ok

238

1.11

0.22

1.1

1.0

7.92

4.33

u/ml

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

238

1.11

0.22

1.1

1.0

7.92

4.33

u/ml

—

Algoneurodystrophy

0.00

0.21

0.0

1.1

—

Other inflammation of vagina/vulva

0.00

0.21

0.0

1.1

—

Emotional disorders starting during childhood or adolescence

0.00

0.21

0.0

1.1

—

Alzheimer’s disease (Atypical or mixed), excluding more controls

0.00

0.21

0.0

1.0

—

Maltreatment syndromes

0.00

0.21

0.0

1.1

—

Other specified/unspecified inflammatory spondylopathies

0.00

0.21

0.0

1.1

—

Non-small cell lung cancer, including Hilmo

1.26

0.20

1.2

1.0

—

2.58

—

Other (not insulin) diabetes medications

267

0.91

0.20

1.0

2.43

5.45

u/ml

—

Contact with and exposure to communicable diseases

122

0.82

0.19

1.0

1.1

—

2.50

—

Benign neoplasm: Rectum

1.20

0.19

1.2

1.0

—

2.93

—

Other or unspecified ileus, impaction or obstruction

1.20

0.19

1.0

1.1

—

2.83

—

Lyme disease

1.21

0.19

1.1

1.0

—

6.08

—

Other disorders of breast

1.18

0.19

1.0

1.1

—

4.21

—

LSIL lesion of the cervix uteri, vagina or vulva

1.15

0.19

1.0

1.1

—

3.50

—

Diabetes, varying definitions

276

1.08

0.18

1.1

6.33

4.39

u/ml

—

Benign neoplasm of other and ill-defined parts of digestive system

1.21

0.18

1.0

1.1

—

3.81

—

Stomatitis and related lesions

1.17

0.17

1.1

1.0

—

3.81

—

Other disorders of amniotic fluid and membranes

1.14

0.17

1.1

—

2.90

—

Obstructed labour due to maternal pelvic abnormality

0.75

0.17

1.0

—

3.62

—

Other and unspecified nonorganic psychotic disorders

0.71

0.16

1.0

—

3.40

—

Spirochaetal infections, other/unspecified

101

1.19

0.16

1.1

1.0

—

6.08

—

Postpartum haemorrhage

101

1.17

0.16

1.1

1.0

—

3.10

—

Effects of foreign body entering through natural orifice

1.11

0.16

1.0

—

7.21

—

Paralytic ileus and intestinal obstruction

0.78

0.15

1.0

1.1

—

3.63

—

Hypertrophy of breast in women and men

0.76

0.15

1.0

1.1

—

4.00

—

Diabetes mellitus

278

1.07

0.15

1.1

6.33

4.39

u/ml

—

Type 2 diabetes

267

1.07

0.15

1.0

6.33

4.39

u/ml

—

Myocardial infarction, strict

100

1.14

0.14

1.1

1.0

—

5.21

—

Other spirochaetal diseases

103

1.17

0.13

1.1

1.0

—

6.08

—

Type 2 diabetes, definitions combined, including avohilmo

256

1.07

0.13

1.0

6.33

4.39

u/ml

—

Malignant neoplasm, wide definition for exclusion

235

1.07

0.13

1.0

7.00

3.08

u/ml

—

Psychiatric diseases

220

1.07

0.13

1.0

6.60

4.94

u/ml

—

Transport accidents

146

1.12

0.13

1.1

—

3.50

—

Diseases of pulp and periapical tissues and dental caries

136

1.09

0.13

1.1

2.00

6.64

u/ml

—

Other antidepressants

226

1.07

0.12

1.1

1.0

7.50

4.00

u/ml

—

Preterm labour and delivery

116

0.86

0.12

1.1

1.0

—

3.05

—

Maternal care for known or suspected malpresentation of fetus

1.16

0.11

1.1

1.0

—

2.90

—

Dental operations

133

1.08

0.10

1.1

1.0

3.93

6.79

u/ml

—

Procreative management

104

1.12

0.10

1.1

—

3.86

—

Other spirochaetal diseases

106

1.13

0.09

1.1

1.0

—

6.08

—

Intracranial injury

211

1.08

0.09

1.0

1.1

2.80

5.89

u/ml

—

Malignant neoplasm of bronchus and lung

1.06

0.08

1.2

1.0

—

2.58

—

Type 1 diabetes, wide definition, subgroup 1

0.86

0.07

1.3

1.1

—

8.25

—

Type 1 diabetes, wide definition

0.83

0.07

1.3

1.1

—

8.25

—

Superficial injury of head

0.87

0.07

1.0

—

7.07

—

Type 1 diabetes

0.86

0.07

1.3

1.1

—

8.25

—

Sub-endpoint used in defining T1D endpoints

0.88

0.06

1.3

1.0

—

5.86

—

Herpesviral [herpes simplex] infections

0.86

0.06

1.0

1.1

—

3.40

—

Persons with potential health hazards related to communicable diseases

150

0.92

0.05

1.0

1.1

—

3.58

—

Diabetes medication

287

0.97

0.04

1.1

1.0

2.43

5.45

u/ml

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

251

1.03

0.04

1.1

1.0

3.00

4.39

u/ml

—

Maternal care for known or suspected abnormality of pelvic organs

0.95

0.01

1.2

1.0

—

2.75

—

Injuries to the shoulder and upper arm

272

1.01

0.00

1.0

1.1

3.60

4.66

u/ml

—

Diabetes, insulin treatment (Kela reimbursement)

263

0.99

0.00

1.1

1.0

3.00

5.25

u/ml

—

Dislocation, sprain and strain of joints and ligaments of knee

236

1.01

0.00

1.0

—

4.98

—

Insulin, fast-acting

121

0.99

0.00

1.2

1.1

—

5.36

—

Intestinal stricture

101

0.99

0.00

1.0

—

7.10

—

Insulin, fast-acting or short human

120

1.00

0.00

1.2

1.1

—

5.40

—

Obstructed labour due to malposition and malpresentation of fetus

101

1.02

0.00

1.1

1.0

—

2.75

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1.03

0.00

1.0

—

10.00

—

Glucagon-like peptide-1 (GLP-1) analogues

1.03

0.00

1.0

—

10.00

—

Other diseases of the digestive system

1.03

0.00

1.0

1.1

—

6.22

—

Deep bite that required surgery

0.00

0.0

1.2

—

Suppurative otitis media, unspecified

0.00

0.0

1.2

—

Ventricular septal defect, a heart condition

0.00

0.0

1.2

—

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

0.00

0.0

1.2

—

Total colectomy operation

0.00

0.0

1.1

—

Mental and behavioural disorders due to use of other stimulants, including caffeine

0.00

0.0

1.1

—

Total colectomy

0.00

0.0

1.1

—

Hodgkin lymphoma, hilmo

0.00

0.0

1.1

—

Other and specified injuries of hip and thigh

0.00

0.0

1.2

—

Other congenital malformations of circulatory system

0.00

0.0

1.1

—

Burn and corrosion of head and neck

0.00

0.0

1.2

—

Somnolence, stupor and coma

0.00

0.0

1.1

—

Toxic effect of alcohol

0.00

0.0

1.2

—

Benign neoplasm: Rectum, anus and anal canal

0.98

0.00

1.2

1.0

—

3.75

—

Malignant neoplasm of respiratory system and intrathoracic organs

0.88

0.00

1.2

1.1

—

2.64

—

Burns and corrosions confined to eye and internal organs

0.00

0.0

1.2

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

0.90

0.00

1.0

—

3.63

—

Lesion of radial nerve

0.00

0.0

1.0

—

Bacterial meningitis

0.00

0.0

1.1

—

Other disorders of iris and ciliary body

0.00

0.0

1.2

—

Effects of other external causes

0.00

0.0

1.1

—

Other and unspecified intracranial injuries

0.00

0.0

1.0

—

Personal history of certain other diseases

0.00

0.0

1.0

—

Other salmonella infections

0.00

0.0

1.0

—

Motorcycle rider injured in noncollision transport accidents

0.00

0.0

1.2

—

Disorders of orbit

0.00

-0.00

0.0

1.1

—

Benign neoplasm: Long bones of lower limb

0.00

-0.00

0.0

1.1

—

Disorders of lacrimal system and orbit in diseases classified elsewhere

0.00

-0.00

0.0

1.0

—

Iridocyclitis in diseases classified elsewhere

0.00

-0.00

0.0

1.2

—

Chorioretinal inflammation

0.00

-0.00

0.0

1.0

—

Seborrhoeic keratosis

0.87

-0.00

1.2

1.1

—

5.42

—

Acute nephritic syndrome

0.00

-0.00

0.0

1.0

—

Use of cabergoline

0.00

-0.00

0.0

1.2

—

Superficial injury of neck

0.00

-0.00

0.0

1.2

—

Exposure to other and unspecified animate mechanical forces

0.00

-0.00

0.0

1.2

—

Symptoms and signs involving emotional state

0.00

-0.00

0.0

1.2

—

Assault by unspecified means

0.00

-0.00

0.0

1.2

—

Amblyopia ex anopsia

0.00

-0.00

0.0

1.1

—

Carcinoma in situ of other and unspecified genital organs

0.00

-0.00

0.0

1.2

—

Bulimia nervosa (incl. atypical)

0.00

-0.00

0.0

1.0

—

Sixth [abducent] nerve palsy

0.00

-0.00

0.0

1.0

—

Other and unspecified nail disorders

0.00

-0.00

0.0

1.2

—

Wide developmental disorders

0.00

-0.00

0.0

1.2

—

Strabismus

0.92

-0.00

1.1

1.0

—

3.56

—

Superficial injuries involving multiple body regions

0.00

-0.00

0.0

1.0

—

Other diseases of gallbladder

0.00

-0.00

0.0

1.1

—

Melanocytic naevi of upper limb, including shoulder

0.00

-0.00

0.0

1.1

—

Cerebral palsy

0.00

-0.00

0.0

1.2

—

Postprocedural disorders of digestive system, not elsewhere classified

0.00

-0.00

0.0

1.1

—

Benign neoplasm: Kidney

0.00

-0.00

0.0

1.0

—

Other and unspecified diseases of blood and blood-forming organs

0.00

-0.00

0.0

1.0

—

Gonococcal infection

0.00

-0.00

0.0

1.2

—

Erythema intertrigo

0.00

-0.00

0.0

1.2

—

Benign neoplasm: Brain, supratentorial

0.00

-0.00

0.0

1.2

—

Benign neoplasm: Anus and anal canal

0.00

-0.00

0.0

1.0

—

Keratoconus

0.00

-0.00

0.0

1.2

—

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

0.00

-0.00

0.0

1.2

—

Burn and corrosion confined to eye and adnexa

0.00

-0.00

0.0

1.2

—

Exposure to other specified electric current

0.00

-0.00

0.0

1.2

—

Parapsoriasis

0.00

-0.00

0.0

1.2

—

0.00

-0.00

0.0

1.2

—

0.00

-0.00

0.0

1.1

—

Intussusception

0.00

-0.00

0.0

1.2

—

Anaemia in chronic diseases classified elsewhere

0.00

-0.00

0.0

1.0

—

Disorders of globe

0.00

-0.00

0.0

1.0

—

Other facial nerve disorders

0.00

-0.00

0.0

1.1

—

Generalized epilepsy, mode (most common among epilepsy diagnosis)

0.00

-0.00

0.0

1.1

—

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

0.00

-0.00

0.0

1.1

—

Other protozoal intestinal diseases

0.00

-0.00

0.0

1.0

—

Specific development disorders of scholastic skills

0.00

-0.00

0.0

1.1

—

Autism spe, excluding more controls

0.00

-0.00

0.0

1.0

—

Major anomalies of jaw size

0.00

-0.00

0.0

1.2

—

Foreign body in ear

0.00

-0.00

0.0

1.2

—

Dislocation, sprain and strain of joints and ligaments at neck level

1.02

-0.00

1.2

1.0

—

3.40

—

Meralgia paraesthetica

0.00

-0.00

0.0

1.0

—

GI-bleeding

0.93

-0.00

1.0

1.1

—

6.22

—

Graves ophthalmopathy

0.00

-0.00

0.0

1.0

—

Certain zoonotic bacterial diseases

0.00

-0.00

0.0

1.2

—

Guttate psoriasis

0.00

-0.00

0.0

1.2

—

Blood alcohol or alcohol intoxication level

0.00

-0.00

0.0

1.2

—

Evidence of alcohol involvement determined by blood alcohol level

0.00

-0.00

0.0

1.2

—

Oral leukoplakia, including avohilmo

0.00

-0.00

0.0

1.0

—

Injury of nerves at wrist and hand level

0.00

-0.00

0.0

1.1

—

Background retinopathy and retinal vascular changes

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of brain

0.00

-0.00

0.0

1.0

—

Injury of muscle and tendon at ankle and foot level

0.00

-0.00

0.0

1.1

—

Intentional self-harm by sharp object

0.00

-0.00

0.0

1.2

—

Malignant neoplasm of bronchus and lung, including Hilmo

0.91

-0.00

1.2

1.0

—

2.58

—

Scissor bite

0.00

-0.00

0.0

1.2

—

Poisoning by medicine

0.92

-0.00

1.0

—

3.00

—

Viral agents as the cause of diseases classified to other chapters

0.00

-0.00

0.0

1.2

—

Open wound of hip and thigh

0.00

-0.00

0.0

1.2

—

Schizotypal disorder

0.00

-0.00

0.0

1.2

—

Wide developmental disorders, excluding more controls

0.00

-0.00

0.0

1.0

—

Mental and behavioural disorders due to cannabinoids

0.00

-0.00

0.0

1.1

—

Other and unspecified epidermal thickening

0.00

-0.00

0.0

1.2

—

Distal bite

0.00

-0.00

0.0

1.1

—

Other disorders of binocular movement

0.00

-0.00

0.0

1.1

—

Prolapse and hernia of ovary and fallopian tube

0.00

-0.00

0.0

1.0

—

Paranoid personality disorder

0.00

-0.00

0.0

1.2

—

Gonococcal infection

0.00

-0.00

0.0

1.0

—

Accidental poisoning by and exposure to alcohol

0.00

-0.00

0.0

1.2

—

Exclusion endpoint for clefts

0.00

-0.00

0.0

1.0

—

Congenital malformations of breast

0.00

-0.00

0.0

1.2

—

Graves ophthalmopathy, strict

0.00

-0.00

0.0

1.0

—

Other salmonella infections

0.00

-0.00

0.0

1.0

—

Endocrine disorders, other/unspecified

0.00

-0.00

0.0

1.1

—

Congenital malformations of breast

0.00

-0.00

0.0

1.2

—

Carrier of infectious disease

0.00

-0.00

0.0

1.1

—

Viral agents as the cause of diseases classified to other chapters

0.00

-0.00

0.0

1.0

—

Other and unspecified disorders of white blood cells

0.00

-0.00

0.0

1.1

—

0.00

-0.00

0.0

1.0

—

Biological medicines for asthma

0.00

-0.00

0.0

1.2

—

Hypogonadotropic hypogonadism

0.00

-0.00

0.0

1.2

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

RNA polymerase III Ab [Units/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS